Dexamethasone Enhances Anti-Emetic Effects of GR38032F in Ferrets
Author Information
Author(s): J. Hawthorn, D. Cunningham
Primary Institution: St Georges Hospital Medical School; Institute of Cancer Research, Royal Marsden Hospital
Hypothesis
Can dexamethasone improve the anti-emetic action of the 5HT3 receptor antagonist GR38032F on cyclophosphamide-induced vomiting in ferrets?
Conclusion
Dexamethasone alone is a weak anti-emetic, but when combined with GR38032F, it significantly enhances its effectiveness against vomiting.
Supporting Evidence
- Dexamethasone alone was shown to be a weak anti-emetic but had significant effects on nausea.
- GR38032F was capable of controlling emesis due to cyclophosphamide in ferrets.
- The combination of GR38032F and dexamethasone resulted in a significant reduction in retching and vomiting.
Takeaway
This study shows that a medicine called dexamethasone can help another medicine work better to stop ferrets from throwing up when they get a certain cancer treatment.
Methodology
Ferrets were treated with cyclophosphamide and observed for vomiting and nausea after receiving GR38032F and/or dexamethasone.
Limitations
The study was conducted on a small sample size of ferrets, which may not fully represent human responses.
Participant Demographics
Albino or fitch ferrets weighing between 500 and 1,200 g.
Statistical Information
P-Value
p<0.0005
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website